Impact of the Herbal Breviscapine on the Pharmacokinetics of Simvastatin in Rats: The Involvement of CYP3A4^[1]

Abstract

The effect of breviscapine injection on the pharmacokinetics of simvastatin and the mRNA expression of hepatic cytochrome P450 (CYP) enzyme was investigated with rats. The rats were pretreated for 8 consecutive days with breviscapine injection (20 mg/kg/day, i. v.), followed by administration of simvastatin through gavage (40 mg/kg). The control rats received the corresponding volume of saline solution for the pretreatment. Blood samples were collected at varied time points after simvastatin administration and the liver was harvested after the last collection of the blood sample for measurement of the CYP3A4 mRNA expression. Pre-treatment with breviscapine injection led to increased plasma concentration of simvastatin, showing 57% increase for AUC_0-∞ (P<0.01)_, 31% increase for C _max (P<0.01), and 36% decrease for the total plasma clearance, compared with the control. Pre-treatment with breviscapine injection also inhibited the mRNA expression of the hepatic CYP3A4. These findings indicate that pre-treatment with breviscapine injection could increase the plasma concentration of simvastatin, possibly by inhibiting the expression of the hepatic CYP3A4, and combined use of breviscapine with simvastatin may improve the simvastatin efficacy and reduce its adverse reactions through reduced its dosage.

¹ Foundation item: Science and technology research project of Heilongjiang province department of education. (12541740) Project of Natural Science Foundation of Heilongjiang Province (2016–2019) 2016069

• References

• 1 Liang G, Zhang G, Liang Y. Efficacy of aspirin combined with statins in the treatment of cerebral infarction. Contemporary Medicine 2013; 19: 54
• 2 Wang C, Li Y, Gao S. et al. Breviscapine Injection Improves the Therapeutic Effect of Western Medicine on Angina Pectoris Patients. PLOS One 2015; 10: e0127961
• 3 Zheng C, Ou W, Shen H. et.al. Combined Therapy of Diabetic Peripheral Neuropathy with Breviscapine and Mecobalamin: A Systematic Review and a Meta-Analysis of Chinese Studies [J]. BioMed Research International 2015; 2015: 680756
• 4 He J, Zhou F, Zhang J. et al. Research Progress on pharmacokinetics of Chinese and Western Medicine [J]. Chinese Journal of Clinical Pharmacology and Therapeutics 2014; 4: 470-475
• 5 Gyu CJ, Min ES, Jaeyoung K. et al. A Comprehensive Review of Recent Studies on Herb-Drug Interaction: A Focus on Pharmacodynamic Interaction [J]. The Journal of Alternative and Complementary Medicine 2016; 4: 262-279
• 6 Koh KK, Quon MJ, Waclawiw MA. Are statins effective for simultaneously treating dyslipidemias and hypertension? [J]. Atherosclerosis 2008; 196: 1-8
• 7 Elsby R, Hilgendorf C, Fenner K. Understanding the critical disposition pathways of statins to assess drug – drug interaction risk during drug development: it’s not just about OATP1B1 [J]. Clinical pharmacology and therapeutics 2012; 92: 584-598
• 8 Neuvonen PJ, Niemi M, Backman JT. Drug interactions with lipid lowering drugs: mechanisms and clinical relevance [J]. Clinical pharmacology and therapeutics 2006; 80: 565-581
• 9 Prueksaritanont T, Ma B, Yu N. The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6 [J]. Br J Clin Pharmacol 2003; 56: 120-124
• 10 Lijia JJ, Kivisto KT, Neuvonen PJ. Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors [J]. Clin Pharmacol Ther. 1998; 64: 477-483
• 11 Jacobson TA. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors [J]. Am J Cardiol 2004; 94: 1140-1146
• 12 Liao SG, Zhang LJ, Li CB. et.al. Rapid screening and identification of caffeic acid and its esters in Erigeron breviscapus by ultra performance liquid chromatography/tandem mass spectrometry [J]. Rapid communications in mass spectrometry: RCM 2010; 24: 2533-2541
• 13 Jie L, Jin LJ, Hua HC. Influence of the Hemorheology, LPO and SOD Level of Simvastain with Brevescapine on Paients with Coronary Heart Disease [J]. Heilongjiang Medical Journal 2014; 38: 787-788
• 14 Zhang S, Pan M, Wei X. Observation of breviscapine combined with simvastatin in the treatment of unstable angina pectoris [J]. Chinese Journal ofmisdiagnosis 2009; 9: 8367-8368
• 15 Zhang L, Wang L. Observation of simvastatin combined with breviscapine in the treatment of diabetic foot [J]. China Practical Medicine 2009; 4: 140-141
• 16 Chen Z, You W, Li C. Curative effect observation of 59 cases of Simvastatin combined with Breviscapine in the treatment of unstable angina pectoris [J]. Journal of Guangdong Medical College 2008; 26: 169-171
• 17 Sugimoto K, Ohmori M, Tsuruoka S. et.al. Different effects of St John’s wort on the pharmacokinetics of simvastatin and pravastatin [J]. Clin Pharmaclo Ther 2001; 70: 518-524
• 18 Bai J, Zhao Y-Y, Su F. et al. Simultaneous determination of simvastatin and fenofibric acid in vivo by dual wavelength HPLC [J]. Chin Hosp Pharm J 2011; 31: 998-1001
• 19 Wang X, Xu Z, Feng J. et al. RP-HPLC Determination of Simvastatin and Its Related Substance Lovastatin [J]. Chinese Journal of Modern Applied Pharmacy 2007; 24: 383-385
• 20 Neuvonen PJ, Niemi M, Backman JT. Drug interactions with lipid lowering drugs: mechanisms and clinical relevance [J]. Clin Pharmacol Ther 2006; 80: 565-581
• 21 Han YL, Li D, Ren B. et.al. Evaluation of impact of Herba Erigerontis injection, a Chinese herbal prescription, on rat hepatic cytochrome P450 enzymes by cocktail probe drugs [J]. J Ethnopharmacol 2012; 139: 104-109